T HE mortality rate from pulmonary embolism (PE) is still high. In the United States some 142,000 fatal cases a year are reported in hospitalized patientsJ 5 Little is known about PE in neurosurgical patients. In four series totaling over 1200 patients, the incidence of fatal pulmonary emboli in cases with acute paraplegia was 2%. 8 It has been reported that most neurosurgical patients die "within minutes of the onset of symptoms" without any possibility of treatment. ~3 This work was designed to investigate the presence of signs and/or symptoms helpful for an early diagnosis of PE in neurosurgical patients, and to evaluate the safety and the usefulness of heparin treatment for PE in these patients.
Clinical Material and Methods
Between January, 1980, and December, 1981, 45 neurosurgical patients, 20 males and 25 females aged 16 to 80 years (mean 50 years), were suspected of PE on the basis of cardiorespiratory signs and symptoms (Table 1) . At the time PE was suspected, 48% of these patients were completely conscious, 26% were partially conscious, and 26% were unconscious. Perfusion lung total cases  23  22  hypoxemia with respiratory alkalosis  19  17  tachycardia  14  16  dyspnea  9  3  hypotension  9  3  chest pain  4  4  deep-vein thrombosis  3*  0  electrocardiographic findings  3  2  chest x-ray findings  1  2  cyanosis  2  1  respiratory arrest  2  0  jugular enlargement 1 0 * In two other instances, signs of deep-vein thrombosis appeared some days after the diagnosis of PE. scanning (PLS) was performed in all 45 cases, and was interpreted according to criteria already described. 6t~ In 23 patients (14 females and nine males) PE was confirmed. Table 2 reports the neurosurgical diagnoses in patients with confirmed and unconfirmed PE. The extent of the pulmonary vascular bed that was obstructed by embolization was assessed from the number of unperfused lung segments at PLS. In order to investigate the diagnostic value of signs and symptoms, we retrospectively evaluated the clinical course of the 23 patients with confirmed PE.
Therapy was started immediately after diagnosis. Heparin was infused intravenously at a dose of 30,000 IU/day. The rate of infusion was adjusted so as to keep the Lee-White coagulation time at between 20 and 30 minutes, since this is considered the only reliable way of documenting achievement of the desired anticoagulation effect. 4'14 Fourteen patients received heparin for 7 days as programmed, five were treated for a shorter period of time, and two received calcium heparin subcutaneously for 7 days. Two patients were not treated: one because of intracranial hemorrhage and the other for hypoprothrombinemia and bleeding gastritis. Two patients died: one on the 1st day of heparin infusion, the other after 1 day of calcium heparin treatment. In 11 patients, PLS was repeated 1 week after diagnosis. The other 10 surviving patients were followed through the evolution of their clinical manifestations. No attempt to prevent deep-vein thrombosis (DVT) or to institute alternative treatment was made in these patients.
Summary of Cases
In the 23 patients with confirmed PE, the mean fraction of the pulmonary vascular bed obstructed by emboli was 44.5%. Thus, the degree of PE in this series was relatively high when compared with that (25% obstruction) of the urokinase pulmonary embolism trial. ~ Correspondingly, impairment of gas exchange was severe, with PaO2 averaging 56.5 mm Hg.
Retrospective analysis of the clinical course of the 23 patients with confirmed PE revealed some previous (Table 3) . These episodes were less serious than those that later caused the suspicion of PE. In these overlooked or misdiagnosed clinical events, we found the same signs and symptoms that subsequently prompted the diagnostic PLS (Table 4) , with the exception of cyanosis, respiratory arrest, and jugular enlargement. These latter signs probably correspond to a wider extension of PE that occurs only in the more advanced stages.
The diagnosis made in the 22 patients in whom the suspicion of PE was not confirmed is given in Table 5 . As reported in the literature, ~'3 the incidence of pneu- 
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FIG. 1.
Interval between surgery and institution ofheparin therapy in the 16 patients with pulmonary embolism. In two patients (hatched rectangles), in whom heparin therapy had been instituted on the 2nd and 5th day after surgery, bleeding in the surgical area occurred on the 4th and 3rd day of heparin therapy, respectively. monia and atelectasis is high in patients with placement ofa nasogastric tube. In two patients a definite diagnosis could not be made, and the clinical manifestations that had raised the suspicion of PE disappeared spontaneously. Table 6 gives the results of heparin treatment and the clinical course in 23 patients with confirmed PE. Twenty-one patients survived: 14 were clinically improved and seven unchanged at the end of 1 week. Hemorrhage occurred in the two untreated patients and in nine of the 21 treated patients, but was controlled. Table 7 lists the site of bleeding in the patients who underwent anticoagulant therapy. In seven patients hemorrhage occurred in the immediate postoperative period, but only two had bleeding in the surgical area (Fig. 1) . In these two patients, heparin therapy was instituted on the 2nd and 5th day after surgery, and bleeding occurred on the 4th and 3rd day of heparin therapy, respectively. In patients with hemorrhagic complications, the hematocrit decreased an average of 19%; in only one instance did the reduction reach 38 %.
Discussion
Pulmonary embolism is usually associated with an increased mortality rate. z~j6 This mortality rate seems even higher in neurosurgical patients according to a very recent review. '3 This may be explained partly by the additional difficulties of making an early diagnosis of PE in this type of patient, and partly because the danger of bleeding at the operative site inhibits the use of anticoagulant treatment.
In our 45 patients, unexplained tachycardia (in 30 cases or 67%) and hypoxemia with respiratory alkalosis (in 36 cases or 80%) were the indicators that most frequently prompted us to perform PLS. It is remarkable that, using these two simple indicators, it is possible to select a group of neurosurgical patients in whom the a priori probability of having PE is very high. Hypotension, although less frequent (present in 12 (27%) of our 45 patients) appears a useful finding since it is relatively specific. It was found in nine (39%) of the 23 patients with confirmed PE and in three (14%) of the 22 with unconfirmed PE. Dyspnea and chest pain cannot be assessed in unconscious patients; however, in spite of the specificity of the former (equal to that of hypotension), these findings determined the selection of only two of the 45 neurosurgical patients. Deep-vein thrombosis was of little help in selecting patients with PE. Only 10% to 17% of neurosurgical patients with documented DVT have clinical symptoms or signs of venous thrombosis. 8'8 Furthermore, our data suggest, in agreement with the literature, '3 that in many patients DVT will be recognized after the development of PE. The role of the electrocardiogram (EKG) and of chest x-ray films in suggesting PE was small in our series. However, the significance of EKG could be increased if repeated tracings are evaluated by a specifically trained cardiologist. 7 Chest x-ray films might also contribute if the appearance of the pulmonary artery is properly evaluated.~2 Other manifestations were of minor relevance in suggesting PE.
Delay in diagnosis may account for the most severe cases of PE. Our data indicate that a certain number of episodes of PE are overlooked or misdiagnosed, and the severity of the disease is built up through recurrent episodes, s Anticoagulant treatment is considered a dangerous procedure in neurosurgical patients. 13 In our series, hemorrhagic complications due to full-dose heparin infusion did not appear more severe or more frequent than those observed when heparin was given for a shorter period or subcutaneously. None of the complications was fatal. It is noteworthy that, in three of nine instances, the bleeding was gastric. It is known that this may occur independent of anticoagulant treatment in this type of patient, 9'~7 Finally, survival in our series of 21 neurosurgical patients with PE who were treated with heparin amounted to 90% of cases, with an improvement rate of 68% at 1 week in the 19 survivors,
